ACR® is proud to join Fight Colorectal Cancer as one of 34 partner organizations supporting the 2026 United in Blue installation on the National Mall in Washington, DC. As part of its March awareness campaign, Fight CRC is rallying partners from diverse communities and sectors to unite in the fight against colorectal cancer. A rally occurred March 1, that brought together colorectal cancer survivors, advocates, and leaders in the field. ACR was represented by survivor Alicia Blakey, Manager, Economic Policy. ACR CEO Dana H. Smetherman, MD, MPH, MBA, FACR, submitted a video highlighting ACR’s vital role in this work.
More than 27,000 blue flags will cover the Mall through March 14, each representing a person under 50 projected to be diagnosed with colorectal cancer by 2030. This powerful visual display follows new American Cancer Society research showing colorectal cancer has become the deadliest cancer for Americans under 50.
The installation was made possible through the dedication of 34 partner organizations, including ACR, and more than 400 volunteers that placed each flag to highlight the urgency of early detection, research and solutions to address rising colorectal cancer rates. As a partner, ACR is committed to advancing early detection, supporting evidence-based screening guidelines, and helping ensure that lifesaving imaging and diagnostic services are accessible for all communities.
Access the press release for United in Blue.
For more information or if you have questions, contact Alicia Blakey, ACR Manager of Economic Policy.
ACR Backs Ultrasound Guidance for Trigger Point Care
ACR urges Medicare to cover ultrasound guidance for high‑risk trigger point injections to improve safety and accuracy.
Read moreACR Supports Bill to Stabilize Medicare Physician Pay
ACR backs bipartisan H.R. 8163 which will stabilize Medicare physician pay by easing budget neutrality, fixing data errors, and capping annual cuts.
Read moreACR Flags Concern With White House FY 2027 Budget Request
ACR raises concerns about Trump’s FY2027 budget, which cuts NIH by $6B, caps indirect costs, restructures institutes, and reduces ARPA‑H funding.
Read more